Atypical antipsychotics, prolactin, cholesterol and bone mineral density in patients with chronic schizophrenia - a preliminary report

被引：0
|
作者：
Won, SH
Kwak, KP
Yun, HD
Kang, BJ
Shin, IH
机构：
[1] Taegu Catholic Univ Hosp, Dept Psychiat, Taegu, South Korea
[2] Dongguk Univ, Gyeongju Hosp, Dept Psychiat, Gyeongju, South Korea
[3] Taegu Catholic Univ Hosp, Dept Internal Med, Taegu, South Korea
[4] Gyunbuk Univ Hosp, Dept Psychiat, Taegu, South Korea
[5] Taegu Catholic Univ, Coll Med, Dept Biostat, Taegu, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2004年 / 14卷
关键词：
D O I：
10.1016/S0924-977X(04)80277-3
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S257 / S257
页数：1
相关论文
共 50 条
  • [21] Low bone mineral density associated with increased prolactin and aging in psychiatric patients treated with prolactin-elevating antipsychotics
    Kinon, BJ
    Liu, H
    Ahl, J
    Lamberson, S
    INTERNATIONAL PSYCHOGERIATRICS, 2003, 15 : 338 - 338
  • [22] The bone mineral density in the Korean male patients with chronic schizophrenia and chronic alcoholism
    Shim, J. C.
    Kim, J. G.
    Jae, Y. M.
    Kim, S. G.
    Kim, H. C.
    Oh, M. K.
    Jung, D. U.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S406 - S406
  • [23] The prevalence of bone mineral density loss in the Korean patients with chronic schizophrenia
    Shim, J. C.
    Jung, D. U.
    Yoon, S. H.
    Kim, J. G.
    Jae, Y. M.
    Choe, B. M.
    Kim, H. C.
    Kim, S. G.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2006, 16 : S403 - S403
  • [24] Efficacy of the new formulations of atypical antipsychotics in patients with chronic schizophrenia
    Vasile, D.
    Vasiliu, O.
    Vasiliu, D.
    Vasile, F.
    EUROPEAN PSYCHIATRY, 2020, 63 : S550 - S551
  • [25] Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia
    Mori, K
    Nagao, M
    Yamashita, H
    Morinobu, S
    Yamawaki, S
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2004, 28 (04): : 659 - 665
  • [26] Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study
    Park, Young-Min
    Lee, Seung-Hwan
    Lee, Bun-Hee
    Lee, Kyu Young
    Lee, Kye-Seong
    Kang, Seung-Gul
    Lee, Hwa-Young
    Kim, Won
    PSYCHIATRY RESEARCH, 2016, 239 : 184 - 189
  • [27] Bone mineral density and bone metabolism in patients with schizophrenia
    Gasser, RW
    Hummer, M
    Malik, P
    Finkenstedt, G
    Hofer, A
    Kemmler, G
    Naveda, RCM
    Oehl, M
    Fleischhacker, WW
    BONE, 2003, 33 (05) : S14 - S14
  • [28] BONE-MINERAL DENSITY IN PATIENTS WITH UROLITHIASIS - PRELIMINARY-REPORT
    ALHAVA, EM
    JUUTI, M
    KARJALAINEN, P
    SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY, 1976, 10 (02): : 154 - 156
  • [29] EFFECT OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON PLASMA PROLACTIN LEVELS IN SCHIZOPHRENIA
    Bilal, Muhammad Sami
    Rana, Mowadat Hussain
    GOMAL JOURNAL OF MEDICAL SCIENCES, 2014, 12 (03): : 142 - 146
  • [30] Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics
    Lindenmayer, JP
    Czobor, P
    Volavka, J
    Citrome, L
    Sheitman, B
    McEvoy, JP
    Cooper, TB
    Chakos, M
    Lieberman, JA
    AMERICAN JOURNAL OF PSYCHIATRY, 2003, 160 (02): : 290 - 296
12345